GeneDx (WGS) Competitors $130.44 +3.23 (+2.53%) As of 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock WGS vs. HIMS, GH, RDNT, SHC, OPCH, BTSG, NAKA, CON, SGRY, and PRVAShould you be buying GeneDx stock or one of its competitors? The main competitors of GeneDx include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), Sotera Health (SHC), Option Care Health (OPCH), BrightSpring Health Services (BTSG), KindlyMD (NAKA), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. GeneDx vs. Its Competitors Hims & Hers Health Guardant Health RadNet Sotera Health Option Care Health BrightSpring Health Services KindlyMD Concentra Group Holdings Parent Surgery Partners Privia Health Group GeneDx (NASDAQ:WGS) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation. Which has better valuation & earnings, WGS or HIMS? Hims & Hers Health has higher revenue and earnings than GeneDx. Hims & Hers Health is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGeneDx$305.45M12.27-$52.29M$0.052,608.90Hims & Hers Health$2.01B5.42$126.04M$0.8060.31 Do institutionals and insiders believe in WGS or HIMS? 61.7% of GeneDx shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 29.6% of GeneDx shares are owned by insiders. Comparatively, 13.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more risk and volatility, WGS or HIMS? GeneDx has a beta of 2.04, suggesting that its share price is 104% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.14, suggesting that its share price is 114% more volatile than the S&P 500. Is WGS or HIMS more profitable? Hims & Hers Health has a net margin of 9.63% compared to GeneDx's net margin of 0.39%. Hims & Hers Health's return on equity of 26.26% beat GeneDx's return on equity.Company Net Margins Return on Equity Return on Assets GeneDx0.39% 16.51% 9.35% Hims & Hers Health 9.63%26.26%13.06% Do analysts prefer WGS or HIMS? GeneDx presently has a consensus target price of $101.63, indicating a potential downside of 22.09%. Hims & Hers Health has a consensus target price of $38.92, indicating a potential downside of 19.35%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than GeneDx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GeneDx 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Does the media favor WGS or HIMS? In the previous week, Hims & Hers Health had 14 more articles in the media than GeneDx. MarketBeat recorded 30 mentions for Hims & Hers Health and 16 mentions for GeneDx. Hims & Hers Health's average media sentiment score of 1.13 beat GeneDx's score of 0.71 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GeneDx 9 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 19 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHims & Hers Health beats GeneDx on 11 of the 16 factors compared between the two stocks. Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WGS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WGS vs. The Competition Export to ExcelMetricGeneDxMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.75B$7.59B$5.75B$9.89BDividend YieldN/A2.66%6.66%4.49%P/E Ratio2,612.2078.1782.9726.58Price / Sales12.2745.86500.68162.32Price / Cash126.5424.8225.7028.92Price / Book13.5219.2910.796.52Net Income-$52.29M$238.91M$3.29B$266.21M7 Day Performance1.12%-1.56%-0.07%-0.96%1 Month Performance20.39%1.49%6.98%3.61%1 Year Performance340.40%10.58%49.86%24.03% GeneDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WGSGeneDx1.8722 of 5 stars$130.45+2.5%$101.63-22.1%+314.0%$3.75B$305.45M2,612.201,200HIMSHims & Hers Health3.3304 of 5 stars$44.07-2.8%$38.92-11.7%+207.2%$10.25B$1.48B55.091,637Positive NewsGHGuardant Health3.8392 of 5 stars$63.50+0.1%$57.50-9.4%+164.8%$7.91B$739.02M-18.962,021News CoveragePositive NewsAnalyst ForecastGap DownRDNTRadNet4.0205 of 5 stars$71.29+1.0%$71.60+0.4%+14.2%$5.43B$1.83B-356.4311,021Positive NewsAnalyst ForecastSHCSotera Health2.3448 of 5 stars$16.50+0.6%$16.00-3.0%+4.0%$4.66B$1.10B206.283,000Positive NewsGap DownOPCHOption Care Health4.7752 of 5 stars$28.59+2.4%$35.75+25.0%-10.6%$4.53B$5.00B22.878,088Positive NewsBTSGBrightSpring Health Services1.6684 of 5 stars$23.93-0.2%$25.67+7.3%+92.3%$4.25B$11.27B77.2035,000Positive NewsNAKAKindlyMD2.257 of 5 stars$6.32-21.7%N/AN/A$3.04B$2.72M-7.35N/ANews CoverageAnalyst ForecastHigh Trading VolumeCONConcentra Group Holdings Parent2.4046 of 5 stars$23.39+2.3%$27.50+17.6%-0.6%$2.93B$1.90B19.6511,250Positive NewsSGRYSurgery Partners3.3566 of 5 stars$22.82+0.6%$33.00+44.6%-28.4%$2.91B$3.11B-15.9615,000News CoveragePositive NewsPRVAPrivia Health Group3.9881 of 5 stars$21.75+1.7%$28.00+28.7%+20.1%$2.63B$1.74B197.751,140Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies HIMS Competitors GH Competitors RDNT Competitors SHC Competitors OPCH Competitors BTSG Competitors NAKA Competitors CON Competitors SGRY Competitors PRVA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WGS) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersMusk Warns. Trump Acts. Your Retirement May Depend on ItWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WGS Stock Alerts